A study to compare the study medicine (GDC-0810) to another treatment (fulvestrant) in patients with breast cancer
A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy
Cancer Breast Cancer
For the latest version of this information please go to www.forpatients.roche.com